BackMetlife Overview
Metlife Inc

Metlife Target Price

Analysts' average 12-month price target for Metlife is $96.

Get informed when a big investor buys or sells

+ Follow

Share Price

$96.73

Average Target Price

$96.420.3% downside

12 analysts in the last 4 months

High: $105 | Low: $86

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-06Barclays$970.3% upsideOpen
2026-07-15Atlantic Equities$1036.5% upsideOpen
2026-07-10JefferiesSuneet Kamath$1036.5% upsideOpen
2026-07-08UBSMichael Ward$1058.5% upsideOpen
2026-07-07BarclaysAlex Scott$942.8% downsideOpen
2026-07-06Morgan Stanley$1036.5% upsideOpen
2026-06-24Piper Sandler$907% downsideOpen
2026-05-26Piper Sandler$8611.1% downsideOpen
2026-05-21Morgan StanleyBob Huang$933.9% downsideOpen
2026-05-12Wells Fargo$951.8% downsideOpen
2026-05-08Mizuho SecuritiesYaron Kinar$951.8% downsideOpen
2026-05-07BarclaysAlex Scott$933.9% downsideOpen
2026-04-13Mizuho SecuritiesYaron Kinar$933.9% downsideOpen
2026-04-09Evercore ISI$960.8% downsideOpen
2026-04-09UBS$1025.4% upsideOpen
2026-02-12Mizuho Securities$1003.4% upsideOpen
2026-02-10Evercore ISIThomas Gallagher$951.8% downsideOpen
2026-02-05UBS$981.3% upsideOpen
2026-01-14Mizuho Securities$1025.4% upsideOpen
2026-01-13Wells FargoElyse Greenspan$970.3% upsideOpen
2026-01-08UBS$942.8% downsideOpen
2026-01-08Barclays$907% downsideOpen
2026-01-06Evercore ISI$970.3% upsideOpen
2025-12-15Mizuho Securities$1014.4% upsideOpen
2025-12-15Morgan Stanley$1014.4% upsideOpen
2025-10-08Barclays$981.3% upsideOpen
2025-10-07Morgan StanleyBob Huang$970.3% upsideOpen
2025-09-19Piper SandlerJohn Barnidge$8413.2% downsideOpen
2025-09-15Wolfe ResearchTracy Benguigui$951.8% downsideOpen
2025-07-14Morgan StanleyBob Huang$981.3% upsideOpen
2025-04-02Piper SandlerJohn Barnidge$942.8% downsideOpen
2025-02-28Morgan Stanley$10912.7% upsideOpen
2024-10-02Piper SandlerJohn Barnidge$924.9% downsideOpen
2024-09-04BarclaysAlex Scott$915.9% downsideOpen
2024-08-01Bank of America SecuritiesJoshua Shanker$960.8% downsideOpen
2024-07-10Morgan StanleyBob Huang$8314.2% downsideOpen
2024-05-22Argus ResearchKevin Heal$8017.3% downsideOpen
2024-05-06Piper SandlerJohn Barnidge$8215.2% downsideOpen
2024-03-13CFRACatherine Seifert$7720.4% downsideOpen
2024-01-08Goldman SachsAlex Scott$8017.3% downsideOpen
2023-09-14Mizuho SecuritiesBrett Linzey$14549.9% upsideOpen
2023-02-02Morgan Stanley$907% downsideOpen
2023-01-10Morgan Stanley$889% downsideOpen
2023-01-09Goldman Sachs$7819.4% downsideOpen
2023-01-06J.P. Morgan$8017.3% downsideOpen
2022-12-09Jefferies$8215.2% downsideOpen
2022-11-17Morgan Stanley$8710.1% downsideOpen
2022-08-22Credit Suisse$7720.4% downsideOpen
2022-08-17Morgan Stanley$8314.2% downsideOpen
2022-08-04Morgan Stanley$7918.3% downsideOpen

Metlife (MET) FAQ

As of the most recent data, MET shows a target price of $96. Scroll down for historical charts and peer comparison views.

If Metlife moved to the average analyst target of $96, shares would be roughly 0.3% lower than $96.73. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Metlife's earnings trajectory.

Besides this target price page, Stockcircle has Metlife's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $96) with ownership activity and broader fundamentals.

Metlife's target price is $96; compare it with other Finance names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.